Filing Details

Accession Number:
0001179110-17-002951
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-02-22 17:57:34
Reporting Period:
2017-02-17
Filing Date:
2017-02-22
Accepted Time:
2017-02-22 17:57:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1800 Abbott Laboratories ABT Pharmaceutical Preparations (2834) 360698440
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1645118 Jared Watkin 100 Abbott Park Road
Abbott Park IL 60064
Senior Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Without Par Value Acquisiton 2017-02-17 7,393 $0.00 53,955 No 4 A Direct
Common Shares Without Par Value Disposition 2017-02-20 740 $44.69 53,215 No 4 F Direct
Common Shares Without Par Value Disposition 2017-02-21 683 $44.69 52,532 No 4 F Direct
Common Shares Without Par Value Disposition 2017-02-21 300 $44.98 52,232 No 4 S Direct
Common Shares Without Par Value Disposition 2017-02-21 100 $44.98 52,132 No 4 S Direct
Common Shares Without Par Value Disposition 2017-02-21 100 $44.99 52,032 No 4 S Direct
Common Shares Without Par Value Disposition 2017-02-21 55 $44.99 51,977 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 F Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Option (right to buy) Acquisiton 2017-02-17 51,129 $0.00 51,129 $44.40
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
51,129 2018-02-17 2027-02-16 No 4 A Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares Without Par Value 444 Indirect Profit Sharing Trust
Footnotes
  1. These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.
  2. Balance in the Abbott Laboratories Stock Retirement Trust as of February 17, 2017.
  3. Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 17,043 on 02/17/2018, 17,043 on 02/17/2019, and 17,043 on 02/17/2020.